Two More Patents Issued
East Lansing, Michigan (November 14, 2012): Retia Medical, LLC, announced today that two of its patent applications have issued. These patents, US 8,282,569 and US 8,273,031, expand Retia’s broad coverage in the area of cardiovascular signal processing to enable accurate monitoring of critically ill patients using less invasive sensors.
Recent Press Releases:
- Retia Medical Receives FDA 510(k) Clearance for Argos Infinity™, Expanding Cardiovascular Intelligence Across High-Risk Surgical and Critical Care Environments
- Retia Medical CEO Marc Zemel Featured on The State of Medtech Podcast
- Retia signs US distribution Agreement for Argos® Cardiac Output Monitor with Medtronic
- New Study in Anesthesia & Analgesia Demonstrates Frequent Occurrence of Low Cardiac Index Despite Normotension, Using Argos® Monitor